Detail page

Knowledge Web

Person

Harald Hampel (1962-)

Psychiater

Name	Harald Hampel
Time	1962- (Date of birth and death)
Place	Deutschland
Academic degree	Dr.
Profession	Psychiater (characteristic profession)
Variant	H. Hampel Harald-Jürgen Hampel
Related	Klinik und Poliklinik für Psychiatrie und Psychotherapie (München)
Further information	Privatdozent, Habil. 2001, Themenschwerpunkt Alzheimer und Demenz; Facharzt für Psychiatrie Psychiater
Record type	Person
GND-Identifier	114594465
Record ID	114594465
Involved in show all Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force The age-specific comorbidity burden of mild cognitive impairment: a US claims database study Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force Differential response to donepezil in MRI subtypes of mild cognitive impairment Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force A Systematic Review of Clinical Practice Guidelines for Alzheimer’s Disease and Strategies for Future Advancements Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers Designing the next-generation clinical care pathway for Alzheimer’s disease Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline Development of the Blood-Based Alzheimer’s Disease Liquid Biopsy Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study Current state of Alzheimer’s fluid biomarkers Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4 Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment Depressive Störungen über die Lebensspanne : Ätiologie, Diagnostik und Therapie Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment: Design and Cohort Baseline Characteristics of the German Dementia Competence Network Robust automated detection of microstructural white matter degeneration in Alzheimer’s disease using machine learning classification of multicenter DTI data Alzheimer's Disease - Modernizing Concept, Biological Diagnosis and Therapy Alzheimer's disease : modernizing concept, biological diagnosis and therapy ; 14 tables Depressive Störungen über die Lebensspanne : Ätiologie, Diagnostik und Therapie Depressive Störungen über die Lebensspanne : Ätiologie, Diagnostik und Therapie Metabolite profiling of Alzheimer's disease cerebrospinal fluid Reduced hippocampal volume in healthy young ApoE4 carriers : an MRI study Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. Sexual dimorphism in healthy aging and mild cognitive impairment : a DTI study White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease Optimal management of Alzheimer’s disease patients : clinical guidelines and family advice Anticonvulsants in the treatment of aggression in the demented elderly: an update Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment Design and Cohort Baseline Characteristics of the German Dementia Competence Network Alzheimer - Demenz : klinische Verläufe, diagnostische Möglichkeiten, moderne Therapiestrategien Alzheimer - Demenz : klinische Vorläufe, diagnostische Möglichkeiten, moderne Therapiestrategien Ein- und zweidimensionale Gelelektrophorese von postmortalem zerebralem Gewebe bei schizophrenen Erkrankungen : Nachweis immunomodulatorisch wirksamer Proteine Barriadas : Beispiele aus d. Dritten Welt

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Harald Hampel (1962-)

Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway

Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force

The age-specific comorbidity burden of mild cognitive impairment: a US claims database study

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment

Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force

Differential response to donepezil in MRI subtypes of mild cognitive impairment

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force

A Systematic Review of Clinical Practice Guidelines for Alzheimer’s Disease and Strategies for Future Advancements

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Designing the next-generation clinical care pathway for Alzheimer’s disease

Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study

β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification

The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline

Development of the Blood-Based Alzheimer’s Disease Liquid Biopsy

Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study

Current state of Alzheimer’s fluid biomarkers

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease

Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations

Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment

Depressive Störungen über die Lebensspanne : Ätiologie, Diagnostik und Therapie

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment: Design and Cohort Baseline Characteristics of the German Dementia Competence Network

Robust automated detection of microstructural white matter degeneration in Alzheimer’s disease using machine learning classification of multicenter DTI data

Alzheimer's Disease - Modernizing Concept, Biological Diagnosis and Therapy

Alzheimer's disease : modernizing concept, biological diagnosis and therapy ; 14 tables

Depressive Störungen über die Lebensspanne : Ätiologie, Diagnostik und Therapie

Depressive Störungen über die Lebensspanne : Ätiologie, Diagnostik und Therapie

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Reduced hippocampal volume in healthy young ApoE4 carriers : an MRI study

Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study.

Sexual dimorphism in healthy aging and mild cognitive impairment : a DTI study

White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines

White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines.

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease

Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease

Optimal management of Alzheimer’s disease patients : clinical guidelines and family advice

Anticonvulsants in the treatment of aggression in the demented elderly: an update

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment Design and Cohort Baseline Characteristics of the German Dementia Competence Network

Alzheimer - Demenz : klinische Verläufe, diagnostische Möglichkeiten, moderne Therapiestrategien

Alzheimer - Demenz : klinische Vorläufe, diagnostische Möglichkeiten, moderne Therapiestrategien

Ein- und zweidimensionale Gelelektrophorese von postmortalem zerebralem Gewebe bei schizophrenen Erkrankungen : Nachweis immunomodulatorisch wirksamer Proteine

Barriadas : Beispiele aus d. Dritten Welt